Breakfast Technical Briefing on REIT Stocks -- Sabra Health Care REIT, Senior Housing Properties Trust, Healthcare Realty Trust, and Ventas

Thursday, October 5, 2017 Hospital News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, October 5, 2017 /PRNewswire/ --

If you want a Stock Review on SBRA, SNH, HR, or VTR then come over to

and sign up for your free customized report. This morning, covers the Healthcare Facilities REIT space, which owns and operates properties including hospitals, senior housing facilities, skilled nursing facilities, and other medical
office buildings. Lined up for review today are the following equities: Sabra Health Care REIT Inc. (NASDAQ: SBRA), Senior Housing Properties Trust (NASDAQ: SNH), Healthcare Realty Trust Inc. (NYSE: HR), and Ventas Inc. (NYSE: VTR). Daily Stock Tracker published free research reports on these stocks today at:

Sabra Health Care REIT 

Irvine, California-based Sabra Health Care REIT Inc.'s shares declined 0.27%, closing Wednesday's trading session at $21.76. The stock recorded a trading volume of 1.74 million shares. The Company's shares are trading 2.71% below their 50-day moving average. Additionally, shares of the Company, which operates as a REIT in the US, have a Relative Strength Index (RSI) of 42.50.  

On September 19th, 2017, Sabra Health Care REIT (SBRA), Enlivant, and TPG Real Estate jointly announced that SBRA has entered into definitive agreements to acquire a 49% equity interest in entities that collectively own 183 senior housing communities managed by Enlivant. The transaction values the portfolio at $1.62 billion, and SBRA's 49% minority interest investment at $371.0 million.

On September 25th, 2017, research firm CapitalOne initiated an 'Equal Weight' rating on the Company's stock, with a target price of $24 per share. See our free and comprehensive research report on SBRA at:

Senior Housing Properties Trust 

On Wednesday, shares in Newton, Massachusetts-based Senior Housing Properties Trust recorded a trading volume of 626,757 shares. The stock rose 0.41%, ending the day at $19.67. The Company's shares have advanced 3.91% on an YTD basis. The stock is trading above its 50-day moving average by 1.20%. Furthermore, shares of the Company, which invests in senior housing properties in the US, have an RSI of 53.58.  

On September 20th, 2017, Senior Housing Properties Trust announced that its Valley Creek Office Park property in Golden Valley, MN has been designated a BOMA 360 Performance Building by the Building Owners and Managers Association (BOMA) International 360 Performance Program Council. The BOMA 360 Performance Program® sets standards that are often referred to in the market for operational best practices in the Commercial Real Estate industry. SNH free research report is just a click away at:

Healthcare Realty Trust 

Nashville, Tennessee-based Healthcare Realty Trust Inc.'s stock finished the day 0.34% lower at $32.58 with a total trading volume of 290,554 shares. Shares of the Company have advanced 7.45% on an YTD basis. The stock is trading above its 200-day moving average by 0.51%. Additionally, shares of the Company, which engages in ownership, acquisition, management, leasing, and development of properties associated with delivery of healthcare services such as medical office and outpatient facilities, have an RSI of 44.06.  

On October 03rd, 2017, Healthcare Realty Trust announced that it expects to report results for Q3 2017 on November 01st, 2017, after the market closes. On November 02nd, 2017, at 9:00 a.m. CT, the Company expects to hold a conference call to discuss earnings results, quarterly activities, general operations, and industry trends. Simultaneously, a webcast of the conference call will be available under the Investor Relations section of the Company's website. Sign up for your complimentary report on HR at:


Shares in Chicago, Illinois-based Ventas Inc. ended yesterday's session 0.05% lower at $63.65. The stock recorded a trading volume of 2.43 million shares, which was above its three months average volume of 1.42 million shares. The Company's shares have advanced 1.81% since the start of this year. The stock is trading 2.41% below its 200-day moving average. Moreover, shares of Ventas, which engages in investment, management, financing, and leasing of properties in the healthcare industry, have an RSI of 28.99.  

On September 25th, 2017, research firm CapitalOne initiated an 'Equal Weight' rating on the Company's stock, with a target price of $69 per share.

On September 26th, 2017, Ventas announced that it will issue its Q3 2017 earnings release prior to the opening of trading on the NYSE on October 27th, 2017. A conference call will be held the same day at 10:00 a.m. ET to discuss those earnings. The call will be webcast live and can be accessed on the Company's website.  Register for free on and download the latest research report on VTR at:


Daily Stock Tracker: 

Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

DST has not been compensated; directly or indirectly; for producing or publishing this document. 


The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  


DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 


This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store